InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,748.04
(
0.37%
)
Dow Jones
39,512.84
(
0.00%
)
Brent Oil
83.16
(
0.93%
)
Bitcoin
62,817.29
(
2.23%
)
Post# of 144813
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

1234jklm

Send PM Follow Ignore
Followers 19
Posts 4745
Boards Moderated 0
Alias Born 11/10/2016

1234jklm

Re: None

Tuesday, 02/20/2018 2:09:02 AM

Tuesday, February 20, 2018 2:09:02 AM

Post# of 144813
Better imaging since first trial


20 years ago it was difficult to discern the difference between dead cancer cells and fibrotic materials.

So previous readings of efficacy could have been seriously underestimated.

This means the 29% response rate is likely to have been underestimated.

This is no longer the case and we can expect imaging to show greater tumor cell death in our pivotal trial due to greatly improved imaging.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PMCB News
More PMCB News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!